Table 2.
|
First 30′ HD |
Last 30′ HD |
Entire HD |
|||
---|---|---|---|---|---|---|
FO | FO/ECW% | FO | FO/ECW% | FO | FO/ECW% | |
SDANN |
-0.40
*
|
-0.39
*
|
-0.29
#
|
-0.35
*
|
-0.31
#
|
-0.30
*
|
VLF |
-0.37
*
|
-0.39
*
|
-0.25 |
-0.27
#
|
-0.25
#
|
-0.28
*
|
LF% |
-0.09 |
-0.11 |
-0.33
#
|
-0.37
†
|
-0.17 |
-0.16 |
HF% |
0.28
#
|
0.29
#
|
0.13 |
0.17 |
0.19 |
0.30
§
|
LF/HF |
-0.21 |
-0.22 |
-0.31
#
|
-0.34
#
|
-0.22 |
-0.22 |
LZC (2,0.01) |
-0.18 |
-0.17 |
-0.17 |
-0.2 |
-0.13 |
-0.23 |
LZC (2,0.05) |
-0.23 |
-0.26
§
|
-0.15 |
-0.30
§
|
-0.07 |
-0.1 |
LZC (3,0.01) | -0.26 # | -0.26 # | -0.34 | -0.31 # | -0.29 # | -0.27 # |
Correlation coefficients between the hydration status parameters and those HRV indices that reached statistical significance for all 69 patients enrolled in the study. Significant values are indicated in bold.
*Spearman p-value < 0.01, #p-value < 0.05, §Pearson p-value < 0.05.